Citigroup Inc 10x Genomics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 15,886 shares of TXG stock, worth $247,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,886

Previous 23,934 33.63%

Holding current value

$247,821

Previous $465,000 23.01%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.71 - $23.49 $126,434 - $189,047	-8,048 Reduced 33.63%	15,886 $358,000
Q2 2024 Aug 12, 2024	BUY	$19.45 - $37.37 $221,632 - $425,831	11,395 Added 90.88%	23,934 $465,000
Q1 2024 May 10, 2024	SELL	$36.08 - $54.3 $1.32 Million - $1.99 Million	-36,699 Reduced 74.53%	12,539 $470,000
Q4 2023 Feb 09, 2024	BUY	$34.32 - $57.55 $1.31 Million - $2.2 Million	38,287 Added 349.62%	49,238 $2.76 Million
Q3 2023 Nov 09, 2023	BUY	$40.86 - $62.98 $217,252 - $334,864	5,317 Added 94.37%	10,951 $451,000
Q2 2023 Aug 10, 2023	BUY	$50.96 - $58.72 $28,129 - $32,413	552 Added 10.86%	5,634 $314,000
Q1 2023 May 11, 2023	SELL	$35.33 - $55.79 $570,120 - $900,283	-16,137 Reduced 76.05%	5,082 $283,000
Q4 2022 Feb 09, 2023	SELL	$24.4 - $41.3 $129,637 - $219,426	-5,313 Reduced 20.02%	21,219 $773,000
Q3 2022 Nov 10, 2022	SELL	$28.48 - $52.59 $453,401 - $837,232	-15,920 Reduced 37.5%	26,532 $755,000
Q2 2022 Aug 10, 2022	SELL	$36.95 - $82.41 $926,151 - $2.07 Million	-25,065 Reduced 37.12%	42,452 $1.92 Million
Q1 2022 May 12, 2022	BUY	$55.7 - $145.79 $77,311 - $202,356	1,388 Added 2.1%	67,517 $5.14 Million
Q4 2021 Feb 10, 2022	SELL	$135.05 - $182.59 $738,318 - $998,219	-5,467 Reduced 7.64%	66,129 $9.85 Million
Q3 2021 Nov 10, 2021	BUY	$145.58 - $192.14 $10.4 Million - $13.8 Million	71,596 New	71,596 $10.4 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.48B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account